Browsing Category
Pharma Industry News
4724 posts
Business-News-Today.com section for global pharma industry news, Indian pharma sector latest news, pharma sector news today, pharmaceuticals industry news.
Will intravenous oncolytic viruses finally overcome metastatic delivery barriers?
ViroMissile, Inc. expands IDOV-Immune into U.S. cancer centers after FDA IND clearance. Explore what this means for systemic viral oncology.
EC backs higher-dose Wegovy as obesity competition intensifies
Novo Nordisk A/S wins EU approval for 7.2 mg Wegovy. Discover how this shifts obesity competition, reimbursement, and long-term strategy.
Can Japanese patent leverage strengthen Annamycin’s hand in AML?
Moleculin Biotech secures Japanese patent for Annamycin. Explore how this IP move could shape AML strategy and global commercialization plans.
Will pharmacokinetics data support 240 cm2 treatment fields for Ameluz?
Biofrontera Inc. advances Ameluz toward 240 cm2 FDA review. Explore the regulatory, financial, and competitive stakes in dermatology markets.
Aurobindo Pharma (NSE: AUROPHARMA) shares slide after FDA flags compliance gaps at Telangana unit
Aurobindo Pharma shares fell after the US FDA flagged nine issues at a Telangana plant. Find out what it means for compliance, investors, and the stock outlook.
Is biomarker-enriched trial design the key to solving schizophrenia cognition failures?
Can biomarker-enriched trials solve schizophrenia cognition failures? Explore Alto Neuroscience’s strategy and what Phase 2 data could mean next.
Phase III evidence elevates BREZTRI in the competitive asthma landscape
Phase III data position AstraZeneca Plc’s BREZTRI for asthma growth. Discover the strategic, financial, and competitive implications.
Will multi-year kidney function data secure Vanrafia’s long-term positioning?
Novartis Pharma AG’s ALIGN data test whether eGFR slope preservation can confirm Vanrafia’s clinical benefit. Read the full executive analysis.
What KBroVet’s full FDA approval means for Pegasus Laboratories and the veterinary neurology market
Pegasus Laboratories secures full FDA approval for KBroVet, redefining canine epilepsy treatment. Find out what this milestone means for vets and pet owners.
AstraZeneca FY2025 results analysis: How oncology scale, China exposure, and pipeline depth are reshaping long-term earnings power
AstraZeneca’s FY2025 results reveal what’s driving growth, where risks are building, and how pipeline depth could shape earnings beyond 2030. Read the full analysis.